Sunday, September 19, 2021

Tag: Neuralstem

Stem Cell-Based Phase I Trial to Repair Spinal Cord Injuries Produces Encouraging Results

First-in-human clinical study found improved motor and sensory function in three of four participants Writing in the June 1 issue of Cell Stem Cell,...

The Race To Treat Spinal Cord Injury: A Comparative Analysis

Summary Four biotech companies are pursuing the treatment of spinal cord injury with the use of stem cell transplantation. Each company demonstrated efficacy in pre-clinical studies. The...

Neuralstem spinal cord injury stem cell trial approved to commence at University Of California

Neuralstem, announced that the Institutional Review Board of the University of California, San Diego, School of Medicine has approved the phase I safety trial...